Quantcast

Posts related to ‘AZN’

24/7 Wall St. Closing Bell — July 6, 2012: Weak Job Numbers, No Love for Software

Posted: July 6, 2012 at 4:05 pm

The three major US stock indexes opened sharply lower this morning following a tepid report on US job growth. The US economy managed to create just 80,000 jobs in June, ...
Read Full Story »

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

Posted: June 30, 2012 at 9:45 am

Some mergers are very straight-forward, and others are just odd.  Now we have an answer over whether or not Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) was going to be acquired or ...
Read Full Story »

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Posted: June 5, 2012 at 8:16 am

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) is back in the rumor mill as far as a buyout, but this time the price appears to be more finite.  We have heard enough ...
Read Full Story »

24/7 Wall St. Closing Bell (WPI, AZN, ANF, SPWR, YGE, COST, MERU, ACI, VECO, PBY, ADM, CPO, AVP, DPZ, PFE, VLO, ABX, JDSU, MRO, FSLR, V, PFCB, DAL, CHK)

Posted: May 1, 2012 at 4:03 pm

The major US stock indexes opened flat this morning but started to move higher following the better-than-expected ISM report on manufacturing (our coverage here). Construction spending in the US was ...
Read Full Story »

Stock Upgrades And Downgrades

Posted: May 1, 2012 at 8:32 am

Canaccord maintains its buy rating on Hologic (NASDAQ: HOLX) after it announced a buyout of Gen-Probe for $3.7. Canaccord  also reiterated its buy rating on Watson Pharmaceuticals (WPI: NYSE) Goldman Sachs upgraded Community Health ...
Read Full Story »

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

Posted: April 27, 2012 at 9:15 am

Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is supposed to be acquired by a larger drug company.  It is one of the biggest public merger rumors out there. At least that is the belief ...
Read Full Story »

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Posted: April 23, 2012 at 2:54 pm

Ardea Biosciences, Inc. (NASDAQ: RDEA) is soaring today on news that AstraZeneca PLC (NYSE: AZN) is paying about $1.26 billion to acquire the company.  With another small-cap to mid-cap biotech and ...
Read Full Story »

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Posted: April 23, 2012 at 7:59 am

Diabetes drug maker Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) has hired bankers and lawyers to help the company find a buyer. In February Amylin turned down a $3.5 billion ($22/share) offer ...
Read Full Story »

Targacept Gets Mixed Results on Drug Trials (TRGT, AZN)

Posted: March 27, 2012 at 9:41 am

Development stage drug maker Targacept Inc. (NASDAQ: TRGT) is having its troubles these days. Earlier this month the company said it would not seek US Food and Drug Administration approval ...
Read Full Story »

Media Digest (3/27/2012) Reuters, WSJ, NYT, FT, Bloomberg

Posted: March 27, 2012 at 6:38 am

Increasing numbers of mutual funds have performances tied to huge investments in Apple (NASDAQ: AAPL). (Reuters) Tim Cook, Apple’s CEO, is in China to address production labor problems. (Reuters) The ...
Read Full Story »

Teva Launches Generic Seroquel on First Day of Patent Loss (TEVA, AZN)

Posted: March 26, 2012 at 2:29 pm

We noted earlier today that AstraZeneca plc (NYSE: AZN) had lost a patent ruling and that the company’s anti-pyschotic drug Seroquel lost its patent protection today. That’s all it took ...
Read Full Story »

AstraZeneca Loses Patent Fight (AZN)

Posted: March 26, 2012 at 7:36 am

Late last Friday, drug maker AstraZeneca PLC (NYSE: AZN) lost its court fight to prevent a generic version of its anti-psychotic drug Seroquel from reaching the US market. The company ...
Read Full Story »

Targacept Slammed on Failed Drug Trial (TRGT, AZN)

Posted: March 20, 2012 at 12:44 pm

Drug developer Targacept Inc. (NASDAQ: TRGT) and partner AstraZeneca plc (NYSE: AZN) today announced that they will not file for regulatory approval on an anti-depressant drug called TC-5214 following a ...
Read Full Story »

24/7 Wall St. Closing Bell (SIRI, IBM, AZN, URBN, ZOLT, YUM, MT, BP, KO, EMR, LPX, MNI, CSTR, SPF, NSU, BPAX)

Posted: February 7, 2012 at 4:06 pm

US equity markets opened lower this morning, but after the first hour or so of trading, the three major indexes moved to positive territory where they remained for the rest ...
Read Full Story »

Top Analyst Upgrades & Downgrades (AON, AZN, CSCO, DLR, DRIV, HSIC, IBM, PBY, CRM, SNH, SSW, SIRI, SOHU, SXL, THO, URBN, ZOLT)

Posted: February 7, 2012 at 8:12 am

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Tuesday morning. AON Corporation (NYSE: AON) Cut to Neutral at ...
Read Full Story »